No Data
No Data
Jiahe Biotech-B (06998) has reached a major acquisition agreement with Yiteng Medicine, boosting the development of domestic innovative drugs.
On October 7th, Jiahao Biology-B (06998) announced a heavy acquisition with Yiteng Medicine, expecting to bring complementary and synergistic effects to both parties, and lay a good foundation for the sustainable development of the enlarged group after the merger is completed.
Hong Kong stock market anomaly | Jiahe Life Sciences-B (06998) resumed trading with a nearly 88% high opening, planning to acquire Yiteng Pharmaceuticals Group through consolidation. The company will be renamed as 'Yiteng Jiahe'.
Jiahe Biology-B (06998) resumed trading today, opening nearly 88% higher in the morning. As of the time of writing, it has risen by 87.88%, trading at 3.1 Hong Kong dollars, with a turnover of 1.1811 million Hong Kong dollars.
Express News | Genor Biopharma - Consideration of Proposed Merger Is to Be Wholly Settled by Way of Issuing Consideration Shares
Express News | Genor Biopharma - Co Will Acquire Edding Group Company by Way of Merger
Express News | Genor Biopharma - on 13 Sept Co Entered Into Merger Agreement
GENOR-B: 2024 Interim Report
No Data
No Data